SCOPUS 정보 검색 플랫폼

Volumn 84, Issue 2, 2002, Pages 241-244

Phase II trial of pyrazoloacridine in patients with persistent or recurrent endometrial carcinoma: A Gynecologic Oncology Group study

(6) Plaxe, Steven C a Blessing, John A b Husseinzadeh, Nader c Webster, Kenneth D d Rader, Janet S e Dunton, Charles J f

a UNIVERSITY OF CALIFORNIA (United States)

b ROSWELL PARK CANCER INSTITUTE (United States)

c UNIVERSITY OF CINCINNATI MEDICAL CENTER (United States)

d LERNER RESEARCH INSTITUTE (United States)

e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE (United States)

f THOMAS JEFFERSON UNIVERSITY (United States)

Author keywords

9 methoxy acridine; Noncycling cells

Indexed keywords

2 (2 DIMETHYLAMINOETHYL) 9 METHOXY 5 NITROPYRAZOLO[3,4,5 KL]ACRIDINE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COUGHING; ENDOMETRIUM CARCINOMA; FATIGUE; FEMALE; FEVER; HUMAN; LEUKOPENIA; NEUROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; THROMBOCYTOPENIA; VOMITING; WEIGHT REDUCTION;

EID: 0036166751 PISSN: 00908258 EISSN: None Source Type: Journal
DOI: 10.1006/gyno.2001.6491 Document Type: Article

Times cited : (19)

References (16)

1
- 0025727551
- Systemic treatment of advanced and recurrent endometrial carcinoma: Current status and future directions
- (1991) J Clin Oncol , vol.9 , pp. 1071-1088
- Moore, T.D.¹ Phillips, P.H.² Nerenstone, S.R.³ Cheson, B.D.⁴

2
- 0002947450
- Oral medroxyprogesterone acetate in advanced or recurrent endometrial carcinoma - Results of therapy and correlation with estrogen and progesterone receptor levels: The Gynecologic Oncology Group experience
- Bailieu EE, Iacobelli S, McGuire WL, editors. Park Ridge, NJ: Parthenon
- (1986) Endocrinology and malignancy: proceedings of the First International Congress on Cancer and Hormones , pp. 446-454
- Thigpen, J.T.¹ Blessing, J.A.² DiSaia, P.J.³

3
- 0018770793
- Phase II trial of Adriamycin in the treatment of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
- (1979) Cancer Treat Rep , vol.63 , pp. 21-27
- Thigpen, J.T.¹ Buchsbaum, H.J.² Mangan, C.³ Blessing, J.A.⁴

4
- 0024602787
- Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
- (1989) Gynecol Oncol , vol.33 , pp. 68-70
- Thigpen, J.T.¹ Blessing, J.A.² Homesley, H.D.³

5
- 0001534469
- Phase III trial of doxorubicin ± cisplatin in advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
- abstract 830
- (1993) Proc Am Soc Clin Oncol , vol.12 , pp. 261
- Thigpen, T.¹ Blessing, J.² Homesley, H.³ Malfetano, J.⁴ DiSaia, P.⁵ Yordan, E.⁶

6
- 0033016653
- Persistent chemosensitivity to platinum and/or paclitaxel in metastatic endometrial cancer
- (1999) Gynecol Oncol , vol.73 , pp. 422-423
- Markman, M.¹ Kennedy, A.² Webster, K.³ Kulp, B.⁴ Peterson, G.⁵ Belinson, J.⁶

7
- 0035865401
- Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: A Gynecologic Oncology Group study
- (2001) J Clin Oncol , vol.19 , pp. 1021-1029
- Fleming, G.F.¹ Fowler, J.M.² Waggoner, S.E.³ Copeland, L.L.L.J.⁴ Greer, B.E.⁵ Horowitz, I.⁶ Sutton, G.⁷ Schilder, R.J.⁸ Fracasso, P.M.⁹ Ball, H.G.¹⁰ McGuire, W.P.¹¹

8
- 0028321404
- A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
- (1994) J Clin Oncol , vol.12 , Issue.7 , pp. 1408-1414
- Thigpen, J.T.¹ Blessing, J.A.² DiSaia, P.J.³ Yordan, E.⁴ Carson, L.F.⁵ Evers, C.⁶

9
- 85031469686
- IND No. 36325
- (1993) Annual report to the Food Drug Administration: Pyrazoloacridine NSC No. 366140

10
- 0029045628
- Phase I and pharmacologic studies of pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules
- (1995) J Clin Oncol , vol.13 , pp. 1975-1984
- Rowinsky, E.K.¹ Noe, D.A.² Grochow, L.B.³ Sartorious, S.E.⁴ Bowling, M.K.⁵ Chen, T.L.⁶ Lubejko, B.G.⁷ Kaufmann, S.H.⁸

11
- 0031824186
- Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma
- (1998) Invest New Drugs , vol.16 , pp. 93-96
- Zalupski, M.M.¹ Shields, A.F.² Philip, P.A.³ Kraut, M.⁴ LoRusso, P.⁵ Heilbrun, L.K.⁶ Vaitkevicius, V.⁷

12
- 0030908801
- Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma
- (1997) Cancer Chemother Pharmacol , vol.40 , pp. 225-227
- Zalupski, M.M.¹ Philip, P.A.² LoRusso, P.³ Shields, A.F.⁴

13
- 0035097064
- A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix: A Gynecologic Group study
- (2001) Invest New Drugs , vol.19 , pp. 77-80
- Plaxe, S.C.¹ Blessing, J.A.² Lucci, J.A.³ Hurteau, J.A.⁴

14
- 0033890184
- Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinoma
- (2000) Invest New Drugs , vol.18 , pp. 247-251
- Dodd, P.M.¹ McCaffrey, J.A.² Mazumdar, M.³ Icasaino, E.⁴ Higgins, G.⁵ Herr, H.⁶ Bajorin, D.⁷

15
- 85031465947
- Phase II trial of pyrazoloacridine (PZA) in recurrent platinum sensitive ovarian cancer: A Gynecologic Group study
- in press
- Gynecol Oncol
- Plaxe, S.C.¹ Blessing, J.A.² Bookman, M.A.³ Creasman, W.T.⁴

16
- 0033894907
- Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors
- (2000) Invest New Drugs , vol.18 , pp. 265-267
- Vuky, J.¹ McCaffrey, J.² Ginsburg, M.³ Mariani, T.⁴ Bajorin, D.F.⁵ Bosl, G.J.⁶ Motzer, R.J.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.